Compagnie Lombard Odier sold 1,059 GE HealthCare shares in Q4, while GE HealthCare exceeded Q4 earnings/share estimates.

Compagnie Lombard Odier SCmA sold 1,059 GE HealthCare Technologies shares in Q4, reducing its holdings to 20,938 shares. GE HealthCare exceeded Q4 earnings/share estimates by $0.11, reaching $1.18, and reported $5.20B revenue against analyst expectations of $5.09B. Institutional investors own 79.18% of the company's stock, with overall positive analyst ratings and a consensus price target of $88.73.